Adicet Bio, Inc. (ACET)

Adicet Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	-	24.99	9.73	17.9
Revenue Growth (YoY)	-	-	156.83%	-45.65%	1699.30%
Gross Profit	-	-	24.99	9.73	17.9
Selling, General & Admin	28.29	26.53	26.3	22.22	15.66
Research & Development	99.32	106.04	71.25	47.75	33.93
Operating Expenses	127.62	132.58	97.54	69.97	49.59
Operating Income	-127.62	-132.58	-72.55	-60.24	-31.69
Interest Expense	-0	-0.03	-0.08	-0.18	-0.13
Interest & Investment Income	10.71	9.98	3.76	0.09	0.79
Other Non Operating Income (Expenses)	-0.22	-0.57	-0.92	-0.61	-0.95
EBT Excluding Unusual Items	-117.12	-123.2	-69.79	-60.93	-31.99
Merger & Restructuring Charges	-	-	-	-	-7.1
Impairment of Goodwill	-	-19.46	-	-	-
Asset Writedown	-	-	-	-1.19	-2.3
Other Unusual Items	-	-	-	-	1.9
Pretax Income	-117.12	-142.66	-69.79	-62.12	-39.49
Income Tax Expense	-	-	-	-0.13	-2.82
Net Income	-117.12	-142.66	-69.79	-62	-36.68
Net Income to Common	-117.12	-142.66	-69.79	-62	-36.68
Shares Outstanding (Basic)	88	43	41	31	7
Shares Outstanding (Diluted)	88	43	41	31	7
Shares Change (YoY)	104.14%	4.78%	32.72%	322.85%	242.22%
EPS (Basic)	-1.33	-3.31	-1.70	-2.00	-5.01
EPS (Diluted)	-1.33	-3.31	-1.70	-2.00	-5.01
Free Cash Flow	-93.5	-98.18	-61.55	-64.1	-42.54
Free Cash Flow Per Share	-1.06	-2.28	-1.50	-2.07	-5.81
Gross Margin	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-290.32%	-619.15%	-177.01%
Profit Margin	-	-	-279.27%	-637.19%	-204.87%
Free Cash Flow Margin	-	-	-246.29%	-658.77%	-237.63%
EBITDA	-121.15	-126.48	-69.98	-58.71	-30.47
EBITDA Margin	-	-	-280.02%	-	-170.17%
D&A For EBITDA	6.47	6.1	2.58	1.54	1.23
EBIT	-127.62	-132.58	-72.55	-60.24	-31.69
EBIT Margin	-	-	-290.32%	-	-177.01%

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q